王莹，2025年于哈尔滨医科大学获得肿瘤学专业博士学位，于2025年加入GMU iCAN Lab从事博后研究工作，目前主要研究方向主要聚焦在LNP-siRNA递送放免疫联合治疗肿瘤。现发表一作SCI论文两篇并获得第78批博后面上资助。
Ying Wang received her Ph.D. in Oncology from Harbin Medical University in 2025. She joined the iCAN Lab at Guangzhou Medical University (GMU) as a postdoctoral researcher in 2025. Her current research focuses on LNP–siRNA delivery for radio-immunotherapy combination treatment of cancer. She has published two first-author SCI-indexed papers and has been awarded funding under the 78th Postdoctoral Science Foundation General Program.